We are live on ! Find out more
OA

Operose Advisors Portfolio holdings

AUM $517M
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
-12.99%
1 Year Est. Return
+24.68%
3 Year Est. Return
+68.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
-$2.53M
Cap. Flow
+$18M
Cap. Flow %
12.64%
Top 10 Hldgs %
72.81%
Holding
326
New
7
Increased
35
Reduced
12
Closed
24

Top Buys

Rank Stock Value
1
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$7.05M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$4.06M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$3.6M
4
VOT icon
Vanguard Morningstar Mid-Cap Growth ETF
VOT
+$2.43M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$727K

Top Sells

Rank Stock Value
1
ACWV icon
iShares MSCI Global Min Vol Factor ETF
ACWV
+$585K
2
NUSC icon
Nuveen ESG Small-Cap ETF
NUSC
+$485K
3
MUB icon
iShares National Muni Bond ETF
MUB
+$233K
4
SCHE icon
Schwab Emerging Markets Equity ETF
SCHE
+$102K
5
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$73K

Sector Composition

Rank Sector Weight
1 Financials 4.02%
2 Technology 3.47%
3 Healthcare 1.47%
4 Consumer Discretionary 1.22%
5 Industrials 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLD icon
201
Prologis
PLD
$134B
$20K 0.01%
168
– –
LNT icon
202
Alliant Energy
LNT
$18.3B
$19K 0.01%
320
– –
PPL
203
PPL Corp
PPL
$27.1B
$19K 0.01%
706
– –
QCOM icon
204
Qualcomm
QCOM
$174B
$19K 0.01%
150
– –
BL icon
205
BlackLine
BL
$1.77B
$17K 0.01%
250
– –
COP icon
206
ConocoPhillips
COP
$152B
$17K 0.01%
190
– –
EW icon
207
Edwards Lifesciences
EW
$52.8B
$17K 0.01%
183
– –
LMT icon
208
Lockheed Martin
LMT
$140B
$17K 0.01%
40
– –
OEF icon
209
iShares S&P 100 ETF
OEF
$20.5B
$17K 0.01%
100
– –
TDOC icon
210
Teladoc Health
TDOC
$1.24B
$17K 0.01%
500
+400
+400% +$17K
WBA
211
DELISTED
Walgreens Boots Alliance
WBA
$17K 0.01%
450
– –
D icon
212
Dominion Energy
D
$60.5B
$16K 0.01%
200
– –
MCHP icon
213
Microchip Technology
MCHP
$43B
$16K 0.01%
280
– –
NEM icon
214
Newmont
NEM
$124B
$16K 0.01%
260
– –
TMO icon
215
Thermo Fisher Scientific
TMO
$218B
$16K 0.01%
30
– –
GILD icon
216
Gilead Sciences
GILD
$172B
$15K 0.01%
250
– –
GPC icon
217
Genuine Parts
GPC
$18.6B
$14K 0.01%
105
– –
AZN icon
218
AstraZeneca
AZN
$243B
$13K 0.01%
100
– –
MAN icon
219
ManpowerGroup
MAN
$2.71B
$13K 0.01%
175
– –
SCHA icon
220
Schwab U.S Small- Cap ETF
SCHA
$23.7B
$13K 0.01%
680
– –
ABMD
221
DELISTED
Abiomed Inc
ABMD
$13K 0.01%
53
– –
CINF icon
222
Cincinnati Financial
CINF
$26.6B
$12K 0.01%
100
– –
DFAE icon
223
Dimensional Emerging Core Equity Market ETF
DFAE
$9.83B
$12K 0.01%
512
+3
+0.6% +$73
EXC icon
224
Exelon
EXC
$47.2B
$12K 0.01%
254
– –
LULU icon
225
lululemon athletica
LULU
$13.6B
$12K 0.01%
45
– –
7 8
9
10 11

Similar funds

PDIP
Palo Duro Investment Partners Chicago, Illinois $515M AUM 36.69% 1-Year Est. Return
AGC
Aspen Grove Capital Avon, Colorado $514M AUM 21.8% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
TM
Taproot Management New York $530M AUM
UFF
USA Financial Formulas Ada, Michigan $531M AUM 28.6% 1-Year Est. Return
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
MCCP
Mission Creek Capital Partners San Francisco, California $501M AUM 28.4% 1-Year Est. Return

Operose Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Operose Advisors held 326 positions worth $142M, down 1.7% from $145M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Operose Advisors deployed $18M of net new capital in Q2 2022, opening 7 new positions and adding to 35 existing holdings. Its largest new stake was Coinbase: 2,000 shares worth $94K.

By sector, the portfolio is most concentrated in Financials at 4% of assets, down from 4.4% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares MSCI Global Min Vol Factor ETF, an estimated $585K trimmed.

  • Operose Advisors's largest Q2 2022 buy was Coinbase: 2,000 shares worth $94K.
  • Operose Advisors added most to Vanguard High Dividend Yield ETF in Q2 2022, an estimated $7.05M increase.
  • Operose Advisors's biggest Q2 2022 reduction was iShares MSCI Global Min Vol Factor ETF, cutting an estimated $585K.
  • Operose Advisors fully exited Nuveen ESG Small-Cap ETF in Q2 2022, selling an estimated $485K.
  • Operose Advisors's ten largest holdings make up 73% of its $142M portfolio in Q2 2022.
  • Operose Advisors opened 7 new positions and closed 24 in Q2 2022.
  • Operose Advisors's portfolio value fell 1.7% quarter-over-quarter to $142M.

Based on Operose Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.